What is Fonar Corporation?
FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States.
FONR · Verdict
Moderate reward · moderate risk
FONR stands out on balance sheet and valuation, but watch the growth signal.
Based on 88% data coverage
FONR · Verdict
Interest covered 452.9×
Above average
Rev +2.3% CAGR · earnings -12.5%
Model-based scoring. For information only — not financial advice.
FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments: Medical Equipment, and Physician Management and Diagnostic Services. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 92.74M, and a P/E ratio of 13.3x.
The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.